Peter A. Campochiaro
Elite in Retinal Vein Occlusion

Dr. Peter A. Campochiaro

Ophthalmology
Johns Hopkins Medicine
The Johns Hopkins Hospital
1800 Orleans Street, Maumenee Lobby, Maumenee Lobby, 
Baltimore, MD 

Elite in Retinal Vein Occlusion
Johns Hopkins Medicine
The Johns Hopkins Hospital
1800 Orleans Street, Maumenee Lobby, Maumenee Lobby, 
Baltimore, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991.

Dr. Campochiaro is rated as an Elite provider by MediFind in the treatment of Retinal Vein Occlusion. His top areas of expertise are Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy.

His clinical research consists of co-authoring 156 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 31 articles in the study of Retinal Vein Occlusion.

Residency
UVA Health University Hospital, Ophthalmology, 1982
Specialties
Ophthalmology
Licenses
Ophthalmology in MD
Board Certifications
American Board Of Ophthalmology
Hospital Affiliations
The Johns Hopkins Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Geisinger
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

The Johns Hopkins Hospital
1800 Orleans Street, Maumenee Lobby, Maumenee Lobby, Baltimore, MD 21287
Call: 410-955-5080

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


4 Clinical Trials

Connective Tissue Growth Factor in Patients With Neovascular Age Related Macular Degeneration
Connective Tissue Growth Factor in Patients With Neovascular Age Related Macular Degeneration
Enrollment Status: Terminated
Publish Date: September 26, 2022
Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy
Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy
Enrollment Status: Terminated
Publish Date: September 26, 2022
Intervention Type: Other
A Phase 1b, Randomized, Uncontrolled, Single-masked, Safety, Tolerability, and Pharmacokinetic Study of Multiple Doses of Three Different Concentrations (0.1%, 1.0%, 5.0%) of SAR 1118 Ophthalmic Solution in Human Subjects Undergoing Elective Pars Plana Vitrectomy (PPV)
A Phase 1b, Randomized, Uncontrolled, Single-masked, Safety, Tolerability, and Pharmacokinetic Study of Multiple Doses of Three Different Concentrations (0.1%, 1.0%, 5.0%) of SAR 1118 Ophthalmic Solution in Human Subjects Undergoing Elective Pars Plana Vitrectomy (PPV)
Enrollment Status: Terminated
Publish Date: May 10, 2017
Intervention Type: Drug
Study Phase: Phase 1
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Enrollment Status: Completed
Publish Date: April 28, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

156 Total Publications

Protocol for NAC Attack, a phase-3, multicenter randomized, parallel, double masked, placebo controlled trial evaluating the efficacy and safety of oral N-acetylcysteine (NAC) in patients with retinitis pigmentosa.
Protocol for NAC Attack, a phase-3, multicenter randomized, parallel, double masked, placebo controlled trial evaluating the efficacy and safety of oral N-acetylcysteine (NAC) in patients with retinitis pigmentosa.
Journal: medRxiv : the preprint server for health sciences
Published: November 24, 2025
View All 156 Publications
Similar Doctors
Yannis M. Paulus
Distinguished in Retinal Vein Occlusion
Dr. Yannis M. Paulus
Ophthalmology
Distinguished in Retinal Vein Occlusion
Dr. Yannis M. Paulus
Ophthalmology

The Johns Hopkins Hospital

Baltimore, MD 
 (0.1 miles away)
410-955-5080
Languages Spoken:
English, Greek
See accepted insurances

Yannis M. Paulus, M.D., F.A.C.S., is the Jonas Fridenwald Professor in Ophthalmology, an associate professor in the Johns Hopkins University Department of Ophthalmology and Department of Biomedical Engineering, and a vitreoretinal surgeon at the Wilmer Eye Institute, Johns Hopkins Medicine’s East Baltimore and Columbia locations. Dr. Paulus served as a surgical retina specialist and director of a research laboratory at the University of Michigan Kellogg Eye Center for almost 10 years, where he developed novel imaging systems, lasers and long-lasting therapies and nanotechnologies to allow physicians to determine cellular markers of disease, enabling early diagnosis, improved treatment monitoring and more individualized, personalized precision medicine tailored to each patient’s needs. After earning his bachelor’s degree in chemistry and physics from Harvard University and his medical degree at Stanford University School of Medicine, Dr. Paulus completed an internship at the Sloan-Kettering Cancer Center, a residency in ophthalmology at the Stanford University School of Medicine Byers Eye Institute, and a surgical and medical retina fellowship at Wilmer Eye Institute, Johns Hopkins Medicine. CVhttps://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/Paulus_CV%2021225.pdf. Dr. Paulus is rated as a Distinguished provider by MediFind in the treatment of Retinal Vein Occlusion. His top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal.

Akrit Sodhi
Distinguished in Retinal Vein Occlusion
Dr. Akrit Sodhi
Ophthalmology
Distinguished in Retinal Vein Occlusion
Dr. Akrit Sodhi
Ophthalmology

The Johns Hopkins Hospital

Baltimore, MD 
 (0.1 miles away)
410-955-5080
Languages Spoken:
English, Spanish
See accepted insurances

Akrit Sodhi, M.D, Ph.D., is an Associate Professor of Ophthalmology at the Wilmer Eye Institute and holds the Branna and Irving Sisenwein Professorship in Ophthalmology. Dr. Sodhi specializes in the medical and surgical management of complex vitreoretinal diseases. Dr. Sodhi was trained at the University of California at Los Angeles (UCLA), the University of California at Davis, and the National Institutes of Health. After obtaining his M.D. and Ph.D., he interned at Sinai Hospital in Baltimore and completed his Ophthalmology Residency training at the Wilmer Eye Institute at Johns Hopkins in 2008. He then pursued a fellowship in vitreoretinal surgery at Wilmer where he also served as the Assistant Chief of Service (Chief Resident). Dr. Sodhi joined the faculty of the Retina Division at Wilmer in 2010. His research interests, currently sponsored by grants from the National Eye Institute, include the examination of the role of hypoxia inducible factor (HIF) and HIF-regulated genes in ocular diseases, including diabetic eye disease, age-related macular degeneration, sickle cell retinopathy, retinal vein occlusions, and uveal melanoma. Dr. Sodhi's lab has identified novel therapeutic targets for the treatment of these vision-threatening diseases. Dr. Sodhi is rated as a Distinguished provider by MediFind in the treatment of Retinal Vein Occlusion. His top areas of expertise are Retinal Vein Occlusion, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, and Late-Onset Retinal Degeneration.

Distinguished in Retinal Vein Occlusion
Dr. Joseph B. Harlan
Ophthalmology
Distinguished in Retinal Vein Occlusion
Dr. Joseph B. Harlan
Ophthalmology

Katzen Medical Associates PC

1209 York Rd, 
Lutherville, MD 
 (8.3 miles away)
410-821-9490
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Joseph Harlan is an Ophthalmologist in Lutherville, Maryland. Dr. Harlan is rated as a Distinguished provider by MediFind in the treatment of Retinal Vein Occlusion. His top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Retinal Artery Occlusion, and Age-Related Macular Degeneration (ARMD). Dr. Harlan is currently accepting new patients.

VIEW MORE RETINAL VEIN OCCLUSION DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Campochiaro's expertise for a condition
ConditionClose
  • Elite
  • Age-Related Macular Degeneration (ARMD)
    Dr. Campochiaro is
    Elite
    . Learn about Age-Related Macular Degeneration (ARMD).
    See more Age-Related Macular Degeneration (ARMD) experts
  • Diabetic Macular Edema (DME)
    Dr. Campochiaro is
    Elite
    . Learn about Diabetic Macular Edema (DME).
    See more Diabetic Macular Edema (DME) experts
  • Late-Onset Retinal Degeneration
    Dr. Campochiaro is
    Elite
    . Learn about Late-Onset Retinal Degeneration.
    See more Late-Onset Retinal Degeneration experts
  • Retinal Vein Occlusion
    Dr. Campochiaro is
    Elite
    . Learn about Retinal Vein Occlusion.
    See more Retinal Vein Occlusion experts
  • Retinitis Pigmentosa
    Dr. Campochiaro is
    Elite
    . Learn about Retinitis Pigmentosa.
    See more Retinitis Pigmentosa experts
  • Retinopathy Pigmentary Mental Retardation
    Dr. Campochiaro is
    Elite
    . Learn about Retinopathy Pigmentary Mental Retardation.
    See more Retinopathy Pigmentary Mental Retardation experts
  • Distinguished
  • Diabetic Retinopathy
    Dr. Campochiaro is
    Distinguished
    . Learn about Diabetic Retinopathy.
    See more Diabetic Retinopathy experts
  • Retinal Detachment
    Dr. Campochiaro is
    Distinguished
    . Learn about Retinal Detachment.
    See more Retinal Detachment experts
  • Advanced
  • Cone Dystrophy
    Dr. Campochiaro is
    Advanced
    . Learn about Cone Dystrophy.
    See more Cone Dystrophy experts
  • Cone Rod Dystrophy Amelogenesis Imperfecta
    Dr. Campochiaro is
    Advanced
    . Learn about Cone Rod Dystrophy Amelogenesis Imperfecta.
    See more Cone Rod Dystrophy Amelogenesis Imperfecta experts
  • Cone-Rod Dystrophy
    Dr. Campochiaro is
    Advanced
    . Learn about Cone-Rod Dystrophy.
    See more Cone-Rod Dystrophy experts
  • Doyne Honeycomb Retinal Dystrophy
    Dr. Campochiaro is
    Advanced
    . Learn about Doyne Honeycomb Retinal Dystrophy.
    See more Doyne Honeycomb Retinal Dystrophy experts
  • Endophthalmitis
    Dr. Campochiaro is
    Advanced
    . Learn about Endophthalmitis.
    See more Endophthalmitis experts
  • Stargardt Macular Degeneration
    Dr. Campochiaro is
    Advanced
    . Learn about Stargardt Macular Degeneration.
    See more Stargardt Macular Degeneration experts
View All 10 Advanced Conditions
  • Experienced
  • Adult-Onset Vitelliform Macular Dystrophy (AVMD)
    Dr. Campochiaro is
    Experienced
    . Learn about Adult-Onset Vitelliform Macular Dystrophy (AVMD).
    See more Adult-Onset Vitelliform Macular Dystrophy (AVMD) experts
  • Cataract
    Dr. Campochiaro is
    Experienced
    . Learn about Cataract.
    See more Cataract experts
  • Cataract Removal
    Dr. Campochiaro is
    Experienced
    . Learn about Cataract Removal.
    See more Cataract Removal experts
  • Choroid Plexus Carcinoma
    Dr. Campochiaro is
    Experienced
    . Learn about Choroid Plexus Carcinoma.
    See more Choroid Plexus Carcinoma experts
  • Geographic Atrophy
    Dr. Campochiaro is
    Experienced
    . Learn about Geographic Atrophy.
    See more Geographic Atrophy experts
  • Glaucoma
    Dr. Campochiaro is
    Experienced
    . Learn about Glaucoma.
    See more Glaucoma experts
View All 11 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.